{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T02:22:06Z","timestamp":1792981326804,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.toxicon.2025.108336","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T22:59:04Z","timestamp":1743202744000},"page":"108336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Chronic pelvic pain and botulinum toxin"],"prefix":"10.1016","volume":"258","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4604-0142","authenticated-orcid":false,"given":"Barbara Illowsky","family":"Karp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8700-7197","authenticated-orcid":false,"given":"Pamela","family":"Stratton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.toxicon.2025.108336_bib1","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/01.AOG.0000237100.29870.cc","article-title":"Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial","volume":"108","author":"Abbott","year":"2006","journal-title":"Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.toxicon.2025.108336_bib3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jmig.2024.05.002","article-title":"The burden of pelvic pain associated with endometriosis among women in selected European countries and the United States: a restricted systematic review","volume":"31","author":"As-Sanie","year":"2024","journal-title":"J. Minim. Invasive Gynecol."},{"issue":"6","key":"10.1016\/j.toxicon.2025.108336_bib4","first-page":"851","article-title":"Chronic pelvic pain in women: an epidemiological perspective","volume":"11","author":"Ayorinde","year":"2015","journal-title":"Womens Health"},{"issue":"3","key":"10.1016\/j.toxicon.2025.108336_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/ejp.938","article-title":"Chronic pelvic pain in women of reproductive and post-reproductive age: a population-based study","volume":"21","author":"Ayorinde","year":"2017","journal-title":"Eur. J. Pain"},{"issue":"2","key":"10.1016\/j.toxicon.2025.108336_bib6","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1097\/j.pain.0000000000002287","article-title":"Classification of chronic pain for the international classification of diseases (ICD-11): results of the 2017 international world health organization field testing","volume":"163","author":"Barke","year":"2022","journal-title":"Pain"},{"issue":"12","key":"10.1016\/j.toxicon.2025.108336_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12120803","article-title":"Botulinum toxin in the treatment of headache","volume":"12","author":"Becker","year":"2020","journal-title":"Toxins"},{"issue":"5","key":"10.1016\/j.toxicon.2025.108336_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2019.06.044","article-title":"A randomized, double-blind, placebo-controlled trial of onabotulinumtoxin A trigger point injections for myofascial pelvic pain","volume":"221","author":"Dessie","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.toxicon.2025.108336_bib9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/JU.0000000000000658","article-title":"A randomized, double-blind, controlled trial shows that onabotulinum toxin A nerve blocks do not provide improved pain control in men with chronic scrotal pain","volume":"203","author":"Dockray","year":"2020","journal-title":"J. Urol."},{"key":"10.1016\/j.toxicon.2025.108336_bib10","unstructured":"Engeler D, Baranowsky AP, Berghmans B, et al. EAU Guidelines on Chronic Pelvic Pain. EAU Guidelines. (https:\/\/uroweb.org\/guidelines\/chronic-pelvic-pain). Accessed January 15, 2025."},{"issue":"4","key":"10.1016\/j.toxicon.2025.108336_bib11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/bju.12951","article-title":"Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis\/chronic pelvic pain syndrome: results of a prospective pilot double-blind and randomized placebo-controlled study","volume":"116","author":"Falahatkar","year":"2015","journal-title":"BJU Int."},{"issue":"2","key":"10.1016\/j.toxicon.2025.108336_bib12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.toxicon.2025.108336_bib13","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/bju.14988","article-title":"Pharmacological interventions for treating chronic prostatitis\/chronic pelvic pain syndrome: a Cochrane systematic review","volume":"125","author":"Franco","year":"2020","journal-title":"BJU Int."},{"issue":"29\u201330","key":"10.1016\/j.toxicon.2025.108336_bib14","first-page":"508","article-title":"Chronic primary pelvic pain syndrome in men","volume":"120","author":"Franz","year":"2023","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"10.1016\/j.toxicon.2025.108336_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/00365599.2010.529820","article-title":"A pilot study of botulinum toxin A for male chronic pelvic pain syndrome","volume":"45","author":"Gottsch","year":"2011","journal-title":"Scand. J. Urol. Nephrol."},{"issue":"3","key":"10.1016\/j.toxicon.2025.108336_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8030059","article-title":"Botulinum toxin A for the treatment of overactive bladder","volume":"8","author":"Hsieh","year":"2016","journal-title":"Toxins"},{"issue":"2","key":"10.1016\/j.toxicon.2025.108336_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269828","article-title":"The burden of Chronic Pelvic Pain (CPP): costs and quality of life of women and men with CPP treated in outpatient referral centers","volume":"18","author":"Hutton","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2025.108336_bib18","unstructured":"International Association for the Study of Pain. Definitions of Chronic Pain Syndromes. (https:\/\/www.iasp-pain.org\/advocacy\/definitions-of-chronic-pain-syndromes\/)."},{"issue":"7","key":"10.1016\/j.toxicon.2025.108336_bib19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00192-018-3831-z","article-title":"Methodological approaches to botulinum toxin for the treatment of chronic pelvic pain, vaginismus, and vulvar pain disorders","volume":"30","author":"Karp","year":"2019","journal-title":"Int. Urogynecol. J."},{"issue":"1","key":"10.1016\/j.toxicon.2025.108336_bib20","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1097\/AOG.0000000000005388","article-title":"Botulinum toxin for the management of pelvic floor tension myalgia and persistent pelvic pain: a systematic review and meta-analysis","volume":"143","author":"Knapman","year":"2024","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.toxicon.2025.108336_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12020129","article-title":"Mechanism of action of botulinum toxin A in treatment of functional urological disorders","volume":"12","author":"Lin","year":"2020","journal-title":"Toxins"},{"issue":"2","key":"10.1016\/j.toxicon.2025.108336_bib22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-5347(05)68562-X","article-title":"The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network","volume":"162","author":"Litwin","year":"1999","journal-title":"J. Urol."},{"issue":"12","key":"10.1016\/j.toxicon.2025.108336_bib23","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/aogs.13946","article-title":"Botulinum toxin injection for chronic pelvic pain: a systematic review","volume":"99","author":"Luo","year":"2020","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"3","key":"10.1016\/j.toxicon.2025.108336_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0029-7844(95)00458-0","article-title":"Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates","volume":"87","author":"Mathias","year":"1996","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.toxicon.2025.108336_bib25","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1097\/SPV.0000000000000870","article-title":"Effectiveness of botulinum toxin for treatment of symptomatic pelvic floor myofascial pain in women: a systematic review and meta-analysis","volume":"27","author":"Meister","year":"2021","journal-title":"Female Pelvic Med. Reconstr. Surg."},{"issue":"3","key":"10.1016\/j.toxicon.2025.108336_bib26","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0022-5347(05)66541-X","article-title":"Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index","volume":"165","author":"Nickel","year":"2001","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.toxicon.2025.108336_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/toxins14010025","article-title":"Botulinum toxin-A injection in chronic pelvic pain syndrome treatment: a systematic review and pooled meta-analysis","volume":"14","author":"Panunzio","year":"2022","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.toxicon.2025.108336_bib28","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.euf.2021.01.005","article-title":"The benefits and harms of botulinum toxin-A in the treatment of chronic pelvic pain syndromes: a systematic review by the European association of urology chronic pelvic pain panel","volume":"8","author":"Parsons","year":"2022","journal-title":"Eur. Urol. Focus"},{"issue":"9","key":"10.1016\/j.toxicon.2025.108336_bib29","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1111\/j.1743-6109.2009.01378.x","article-title":"Botulinum toxin type A-a novel treatment for provoked vestibulodynia? Results from a randomized, placebo controlled, double blinded study","volume":"6","author":"Petersen","year":"2009","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.toxicon.2025.108336_bib30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.toxicon.2018.01.017","article-title":"Botulinum toxin treatment of pain syndromes -an evidence based review","volume":"147","author":"Safarpour","year":"2018","journal-title":"Toxicon"},{"issue":"16","key":"10.1016\/j.toxicon.2025.108336_bib31","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1056\/NEJMcp060423","article-title":"Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome","volume":"355","author":"Schaeffer","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.toxicon.2025.108336_bib32","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.urology.2008.09.074","article-title":"Clinical phenotyping of patients with chronic prostatitis\/chronic pelvic pain syndrome and correlation with symptom severity","volume":"73","author":"Shoskes","year":"2009","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.toxicon.2025.108336_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/pcan.2008.42","article-title":"Clinical phenotyping in chronic prostatitis\/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes","volume":"12","author":"Shoskes","year":"2009","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.toxicon.2025.108336_bib34","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/j.pain.0000000000001849","article-title":"John D. Loeser Award Lecture: size does matter, but it isn't everything: the challenge of modest treatment effects in chronic pain clinical trials","volume":"161","author":"Smith","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.toxicon.2025.108336_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2023.107208","article-title":"Botulinum toxin A and neuropathic pain: an update","volume":"232","author":"Spagna","year":"2023","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108336_bib36","doi-asserted-by":"crossref","DOI":"10.1007\/s00192-022-05115-7","article-title":"The efficacy of botulinum toxin a injections in pelvic floor muscles in chronic pelvic pain patients: a systematic review and meta-analysis","author":"Spruijt","year":"2022","journal-title":"Int. Urogynecol. J."},{"issue":"13","key":"10.1016\/j.toxicon.2025.108336_bib37","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJMra1810764","article-title":"Endometriosis","volume":"382","author":"Zondervan","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010125001102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010125001102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T13:00:46Z","timestamp":1745586046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010125001102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":36,"alternative-id":["S0041010125001102"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2025.108336","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic pelvic pain and botulinum toxin","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2025.108336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108336"}}